Multiple myeloma: EHA-ESMO clinical practice guidelines for diagnosis, treatment and follow-up

Saved in:
Bibliographic Details
Main Authors: Dimopoulos, Meletios A. (Author) , Moreau, P. (Author) , Terpos, E. (Author) , Mateos, M. V. (Author) , Zweegman, S. (Author) , Cook, G. (Author) , Delforge, M. (Author) , Hájek, R. (Author) , Schjesvold, F. (Author) , Cavo, M. (Author) , Goldschmidt, Hartmut (Author) , Facon, T. (Author) , Einsele, H. (Author) , Boccadoro, M. (Author) , San-Miguel, J. (Author) , Sonneveld, P. (Author) , Mey, U. (Author)
Format: Article (Journal)
Language:English
Published: 3 February 2021
In: Annals of oncology
Year: 2021, Volume: 32, Issue: 3, Pages: 309-322
ISSN:1569-8041
DOI:10.1016/j.annonc.2020.11.014
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.annonc.2020.11.014
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0923753420431692
Get full text
Author Notes:M.A. Dimopoulos, P. Moreau, E. Terpos, M.V. Mateos, S. Zweegman, G. Cook, M. Delforge, R. Hájek, F. Schjesvold, M. Cavo, H. Goldschmidt, T. Facon, H. Einsele, M. Boccadoro, J. San-Miguel, P. Sonneveld & U. Mey, on behalf of the EHA Guidelines Committee and ESMO Guidelines Committee

MARC

LEADER 00000caa a2200000 c 4500
001 1756909288
003 DE-627
005 20221019103501.0
007 cr uuu---uuuuu
008 210503s2021 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.annonc.2020.11.014  |2 doi 
035 |a (DE-627)1756909288 
035 |a (DE-599)KXP1756909288 
035 |a (OCoLC)1341407703 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Dimopoulos, Meletios A.  |e VerfasserIn  |0 (DE-588)111795188X  |0 (DE-627)871747634  |0 (DE-576)479413746  |4 aut 
245 1 0 |a Multiple myeloma  |b EHA-ESMO clinical practice guidelines for diagnosis, treatment and follow-up  |c M.A. Dimopoulos, P. Moreau, E. Terpos, M.V. Mateos, S. Zweegman, G. Cook, M. Delforge, R. Hájek, F. Schjesvold, M. Cavo, H. Goldschmidt, T. Facon, H. Einsele, M. Boccadoro, J. San-Miguel, P. Sonneveld & U. Mey, on behalf of the EHA Guidelines Committee and ESMO Guidelines Committee 
264 1 |c 3 February 2021 
300 |a 14 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 03.05.2021 
650 4 |a clinical practice guidelines 
650 4 |a diagnosis 
650 4 |a follow-up 
650 4 |a multiple myeloma 
650 4 |a prognosis 
650 4 |a treatment 
700 1 |a Moreau, P.  |e VerfasserIn  |4 aut 
700 1 |a Terpos, E.  |e VerfasserIn  |4 aut 
700 1 |a Mateos, M. V.  |e VerfasserIn  |4 aut 
700 1 |a Zweegman, S.  |e VerfasserIn  |4 aut 
700 1 |a Cook, G.  |e VerfasserIn  |4 aut 
700 1 |a Delforge, M.  |e VerfasserIn  |4 aut 
700 1 |a Hájek, R.  |e VerfasserIn  |4 aut 
700 1 |a Schjesvold, F.  |e VerfasserIn  |4 aut 
700 1 |a Cavo, M.  |e VerfasserIn  |4 aut 
700 1 |a Goldschmidt, Hartmut  |d 1956-  |e VerfasserIn  |0 (DE-588)102258023X  |0 (DE-627)717003809  |0 (DE-576)365637386  |4 aut 
700 1 |a Facon, T.  |e VerfasserIn  |4 aut 
700 1 |a Einsele, H.  |e VerfasserIn  |4 aut 
700 1 |a Boccadoro, M.  |e VerfasserIn  |4 aut 
700 1 |a San-Miguel, J.  |e VerfasserIn  |4 aut 
700 1 |a Sonneveld, P.  |e VerfasserIn  |4 aut 
700 1 |a Mey, U.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Annals of oncology  |d Amsterdam [u.a.] : Elsevier, 1990  |g 32(2021), 3, Seite 309-322  |h Online-Ressource  |w (DE-627)320428796  |w (DE-600)2003498-2  |w (DE-576)098134345  |x 1569-8041  |7 nnas  |a Multiple myeloma EHA-ESMO clinical practice guidelines for diagnosis, treatment and follow-up 
773 1 8 |g volume:32  |g year:2021  |g number:3  |g pages:309-322  |g extent:14  |a Multiple myeloma EHA-ESMO clinical practice guidelines for diagnosis, treatment and follow-up 
787 0 8 |i Ergänzung  |a Dimopoulos, Meletios A.  |t Corrigendum to ‘Multiple myeloma  |d 2022  |w (DE-627)1794622632 
856 4 0 |u https://doi.org/10.1016/j.annonc.2020.11.014  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0923753420431692  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210503 
993 |a Article 
994 |a 2021 
998 |g 102258023X  |a Goldschmidt, Hartmut  |m 102258023X:Goldschmidt, Hartmut  |d 910000  |d 910100  |e 910000PG102258023X  |e 910100PG102258023X  |k 0/910000/  |k 1/910000/910100/  |p 11 
999 |a KXP-PPN1756909288  |e 3921330920 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 03.05.2021"],"id":{"doi":["10.1016/j.annonc.2020.11.014"],"eki":["1756909288"]},"title":[{"title":"Multiple myeloma","title_sort":"Multiple myeloma","subtitle":"EHA-ESMO clinical practice guidelines for diagnosis, treatment and follow-up"}],"recId":"1756909288","language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"3 February 2021","dateIssuedKey":"2021"}],"relHost":[{"origin":[{"publisher":"Elsevier ; Kluwer ; Oxford Univ. Press","dateIssuedDisp":"1990-","publisherPlace":"Amsterdam [u.a.] ; Dordrecht [u.a.] ; Oxford","dateIssuedKey":"1990"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"part":{"extent":"14","year":"2021","pages":"309-322","text":"32(2021), 3, Seite 309-322","issue":"3","volume":"32"},"title":[{"title_sort":"Annals of oncology","title":"Annals of oncology","subtitle":"official journal of the European Society for Medical Oncology"}],"id":{"eki":["320428796"],"zdb":["2003498-2"],"issn":["1569-8041"]},"disp":"Multiple myeloma EHA-ESMO clinical practice guidelines for diagnosis, treatment and follow-upAnnals of oncology","note":["Gesehen am 12.11.20","Ungezählte Beil.: Supplement"],"recId":"320428796","pubHistory":["1.1990 -"],"corporate":[{"roleDisplay":"Herausgebendes Organ","display":"European Society for Medical Oncology","role":"isb"}]}],"person":[{"roleDisplay":"VerfasserIn","family":"Dimopoulos","given":"Meletios A.","display":"Dimopoulos, Meletios A.","role":"aut"},{"role":"aut","display":"Moreau, P.","given":"P.","family":"Moreau","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Terpos","display":"Terpos, E.","role":"aut","given":"E."},{"roleDisplay":"VerfasserIn","family":"Mateos","given":"M. V.","role":"aut","display":"Mateos, M. V."},{"roleDisplay":"VerfasserIn","family":"Zweegman","given":"S.","role":"aut","display":"Zweegman, S."},{"roleDisplay":"VerfasserIn","family":"Cook","given":"G.","role":"aut","display":"Cook, G."},{"family":"Delforge","roleDisplay":"VerfasserIn","given":"M.","role":"aut","display":"Delforge, M."},{"roleDisplay":"VerfasserIn","family":"Hájek","display":"Hájek, R.","role":"aut","given":"R."},{"family":"Schjesvold","roleDisplay":"VerfasserIn","given":"F.","role":"aut","display":"Schjesvold, F."},{"given":"M.","display":"Cavo, M.","role":"aut","roleDisplay":"VerfasserIn","family":"Cavo"},{"roleDisplay":"VerfasserIn","family":"Goldschmidt","role":"aut","display":"Goldschmidt, Hartmut","given":"Hartmut"},{"display":"Facon, T.","role":"aut","given":"T.","family":"Facon","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Einsele, H.","given":"H.","family":"Einsele","roleDisplay":"VerfasserIn"},{"given":"M.","role":"aut","display":"Boccadoro, M.","family":"Boccadoro","roleDisplay":"VerfasserIn"},{"role":"aut","display":"San-Miguel, J.","given":"J.","family":"San-Miguel","roleDisplay":"VerfasserIn"},{"given":"P.","role":"aut","display":"Sonneveld, P.","roleDisplay":"VerfasserIn","family":"Sonneveld"},{"roleDisplay":"VerfasserIn","family":"Mey","given":"U.","role":"aut","display":"Mey, U."}],"physDesc":[{"extent":"14 S."}],"name":{"displayForm":["M.A. Dimopoulos, P. Moreau, E. Terpos, M.V. Mateos, S. Zweegman, G. Cook, M. Delforge, R. Hájek, F. Schjesvold, M. Cavo, H. Goldschmidt, T. Facon, H. Einsele, M. Boccadoro, J. San-Miguel, P. Sonneveld & U. Mey, on behalf of the EHA Guidelines Committee and ESMO Guidelines Committee"]}} 
SRT |a DIMOPOULOSMULTIPLEMY3202